DRIO vs XBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

DRIO

38.8
AI Score
VS
XBIO Wins

XBIO

53.1
AI Score

Investment Advisor Scores

DRIO

39score
Recommendation
SELL

XBIO

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DRIO XBIO Winner
Revenue 3.89M 1.47M DRIO
Net Income -5.38M -1.39M XBIO
Net Margin -138.2% -94.5% XBIO
Operating Income -10.72M -1.47M XBIO
ROE -88.3% -22.8% XBIO
ROA -43.7% -19.9% XBIO
Total Assets 12.33M 6.97M DRIO
Current Ratio 1.89 7.43 XBIO

Relative Price Performance (Last 90 Days)

DRIO 1M: -49.3% · 3M: -56.1% XBIO 1M: -24.4% · 3M: -27.9%

Current Technical Phase

DRIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.1%), weak momentum, RSI 21

RSI (14): 20.7 · Price: $3.42

XBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.9%), weak momentum, RSI 32

RSI (14): 31.7 · Price: $1.90

Fundamentals Snapshot

Metric DRIO XBIO
Market Cap — —
Forward P/E -3.0 -5.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.6% 1.0%
Operating Margin -1.3% -1.5%
EPS -2.28 -1.15
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, XBIO is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.